New hope for stuffy noses: experimental drug targets nasal polyps

NCT ID NCT06639295

First seen Jan 04, 2026 · Last updated Jun 05, 2026 · Updated 25 times

Summary

This study tests an investigational drug called 611 in 243 adults with chronic sinusitis and nasal polyps that haven't been well-controlled by other treatments. The goal is to see if 611 can shrink polyps and ease nasal congestion over 24 weeks. Participants receive either the drug or a placebo, and neither they nor their doctors know which they get.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASAL POLYPS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Site 01

    Beijing, Beijing Municipality, 100730, China

Conditions

Explore the condition pages connected to this study.